Neurofeedback treatment for women with bulimia nervosa
Neurofeedback During Eating: A Novel Mechanistic Treatment for Bulimia Nervosa
This study tests if a new brain training method can help women with bulimia nervosa improve their control over eating and reduce their symptoms.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05614024 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of noninvasive neurofeedback targeting the prefrontal cortex during eating in women diagnosed with bulimia nervosa. Participants will be randomly assigned to receive either real or sham neurofeedback while eating, using a wearable brain imaging device called functional near-infrared spectroscopy (fNIRS). The study aims to assess how this neurofeedback training may enhance inhibitory control and alleviate symptoms associated with bulimia nervosa. Data collection includes assessments before and after the neurofeedback session, along with follow-up evaluations.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 to 45 who meet the diagnostic criteria for bulimia nervosa and have a body mass index between 18.5 and 30 kg/m2.
Not a fit: Patients currently undergoing psychotherapy focused on eating disorder symptoms or those with significant medical or psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve inhibitory control and reduce symptoms of bulimia nervosa in affected individuals.
How similar studies have performed: While the use of neurofeedback in eating disorders is an emerging field, similar studies have shown promise in other conditions, suggesting potential for success in this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Female * Aged 18 to 45 years * Meet diagnostic criteria for bulimia nervosa * Current body mass index greater than or equal to 18.5kg/m2 but under 30kg/m2 * English-speaking Exclusion criteria: * Ongoing medical treatment, major medical condition, or psychiatric disorder that may interfere with study variables or participation * Current psychotherapy focused primarily on eating disorder symptoms * Pregnancy or planned pregnancy, or lactation during the study period * Allergy to ingredients in the standardized meal or in the shake
Where this trial is running
New York, New York
- Center for Computational Psychiatry at the Icahn School of Medicine at Mount Sinai — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Laura A Berner, Ph.D. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sila Sozeri, B.A.
- Email: sila.sozeri@mssm.edu
- Phone: (212) 201-2679
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.